Open AccessReview on Psoriasis Disease
Author(s) -
Prashant S Malpure,
Gayatri R Kadam,
Sakshi D Chitte,
Gaurav S Kale
Publication year - 2022
Publication title -
asian journal of pharmaceutical research and development
Language(s) - English
Resource type - Journals
ISSN - 2320-4850
DOI - 10.22270/ajprd.v10i1.1084
Subject(s) - psoriasis , medicine , disease , dermatology , intensive care medicine , population , pathology , environmental health
Psoriasis is an autoimmune disease characterised by the proliferation of keratinocytes throughout time. On average, it affects 2-5 percent of the world's population. Psoriasis treatment remains difficult due to a variety of factors influencing treatment, including patient compliance and adherence to therapy, delicate patient profiles, psychological factors, and skin as a barrier to topical delivery. Pathophysiology, triggering factors, and clinical categorization were covered in the first section. Topical, oral, biological, parenteral therapy, phototherapy, and phytopharmaceuticals were all covered in the second section.